Baxter International Forecasts FY Adjusted EPS Between $1.85 and $2.05
BAX is trading near its 52-week low of $15.73 (10% above the low).
Summary
Baxter International has issued its full-year adjusted EPS guidance, projecting a range of $1.85 to $2.05. This new financial outlook is a critical piece of information for investors and analysts, directly impacting valuation models and future performance expectations. The guidance comes after a challenging 2025 for the company, which included significant net losses, impairments, product recalls, and legal issues, as highlighted in its last 10-K. Traders will need to integrate this new guidance into their investment theses immediately. The market will now closely watch for further details on the underlying assumptions and how this guidance compares to current analyst consensus.
At the time of this announcement, BAX was trading at $17.33 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $15.73 to $32.68. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.